Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoni

Showing results (141-150 of 325) with videos related to

Pageof 33
Sort By:
Haematologica|January 26, 2019
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agentsChiara Tarantelli, Lu Zhang, Elisabetta Curti, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
International Journal of Cancer|July 29, 2011
Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosisDavide Rossi, Valeria Spina, Francesco Forconi, et al.
Genes, Chromosomes & Cancer|April 28, 2009
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effectLuca Agnelli, Laura Mosca, Sonia Fabris, et al.
British Journal of Haematology|February 1, 2011
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomasDaniela Capello, Annunziata Gloghini, Maurizio Martini, et al.
Cell Reports|April 21, 2015
Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancerAbdullah Alajati, Ilaria Guccini, Sandra Pinton, et al.
Journal of Inflammation Research|March 25, 2025
FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease ProgressionMaoting Hu, Kunlin Yu, Chunlin Wang, et al.
Leukemia & Lymphoma|February 28, 2007
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patientsElías Gracia, Patrizia Froesch, Luca Mazzucchelli, et al.
Haematologica|January 19, 2007
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myelomaLuca Agnelli, Silvio Bicciato, Sonia Fabris, et al.
British Journal of Haematology|September 18, 2025
Comprehensive analysis of <sup>177</sup>Lu-lilotomab satetraxetan in lymphoma cell lines: Implications for precision radioimmunotherapy and combination schemesSebastian Patzke, Luciano Cascione, Katrine B Melhus, et al.
Pageof 33

Showing results (141-150 of 325) with videos related to

Sort By:
Pageof 33
Haematologica|January 26, 2019
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agentsChiara Tarantelli, Lu Zhang, Elisabetta Curti, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
International Journal of Cancer|July 29, 2011
Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosisDavide Rossi, Valeria Spina, Francesco Forconi, et al.
Genes, Chromosomes & Cancer|April 28, 2009
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effectLuca Agnelli, Laura Mosca, Sonia Fabris, et al.
British Journal of Haematology|February 1, 2011
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomasDaniela Capello, Annunziata Gloghini, Maurizio Martini, et al.
Cell Reports|April 21, 2015
Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancerAbdullah Alajati, Ilaria Guccini, Sandra Pinton, et al.
Journal of Inflammation Research|March 25, 2025
FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease ProgressionMaoting Hu, Kunlin Yu, Chunlin Wang, et al.
Leukemia & Lymphoma|February 28, 2007
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patientsElías Gracia, Patrizia Froesch, Luca Mazzucchelli, et al.
Haematologica|January 19, 2007
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myelomaLuca Agnelli, Silvio Bicciato, Sonia Fabris, et al.
British Journal of Haematology|September 18, 2025
Comprehensive analysis of <sup>177</sup>Lu-lilotomab satetraxetan in lymphoma cell lines: Implications for precision radioimmunotherapy and combination schemesSebastian Patzke, Luciano Cascione, Katrine B Melhus, et al.
Pageof 33